Statistics for Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes
Total visits
| views | |
|---|---|
| Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes | 78 |
Total visits per month
| views | |
|---|---|
| May 2024 | 1 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms-1689946.pdf | 87 |
Top country views
| views | |
|---|---|
| United States | 63 |
| Bulgaria | 4 |
| Algeria | 1 |
| Israel | 1 |
| Malaysia | 1 |
| Thailand | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 44 |
| Fairfield | 6 |
| Sofia | 4 |
| Ann Arbor | 2 |
| Cambridge | 2 |
| Houston | 2 |
| Algiers | 1 |
| Andover | 1 |
| Falls Church | 1 |
| Haifa | 1 |
| San Francisco | 1 |
| Seremban | 1 |
| Washington | 1 |